1. Home
  2. TAL vs STVN Comparison

TAL vs STVN Comparison

Compare TAL & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TAL Education Group

TAL

TAL Education Group

HOLD

Current Price

$11.47

Market Cap

6.4B

Sector

Real Estate

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$20.96

Market Cap

7.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TAL
STVN
Founded
2003
1949
Country
China
Italy
Employees
N/A
N/A
Industry
Other Consumer Services
Containers/Packaging
Sector
Real Estate
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
7.4B
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
TAL
STVN
Price
$11.47
$20.96
Analyst Decision
Buy
Buy
Analyst Count
4
4
Target Price
$12.66
$25.38
AVG Volume (30 Days)
2.5M
329.9K
Earning Date
01-22-2026
11-06-2025
Dividend Yield
N/A
0.30%
EPS Growth
136.94
19.61
EPS
0.28
0.60
Revenue
$2,653,037,000.00
$1,373,219,524.00
Revenue This Year
$36.12
$8.42
Revenue Next Year
$23.83
$9.52
P/E Ratio
$39.70
$34.98
Revenue Growth
44.45
6.97
52 Week Low
$8.50
$17.81
52 Week High
$15.30
$28.00

Technical Indicators

Market Signals
Indicator
TAL
STVN
Relative Strength Index (RSI) 52.67 39.09
Support Level $11.05 $20.62
Resistance Level $11.52 $23.88
Average True Range (ATR) 0.25 1.14
MACD 0.04 -0.08
Stochastic Oscillator 78.57 10.68

Price Performance

Historical Comparison
TAL
STVN

About TAL TAL Education Group

TAL Education Group is a smart learning solutions provider in China. It operates a few business lines including enrichment learning, high school academic tutoring, learning technology, and content solutions. Among those business lines, TAL focuses on enrichment learning and content solutions.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Share on Social Networks: